ARCHIVES

AACR Urges FDA to Regulate High Risk Lab-Developed Tests

This article is from The Cancer Letter archive.

Vol. 40 No. 34 | September 12, 2014

Download PDF Visit The Full Archive

Related Articles

Insurer Declines To Cover Avastin For Breast Cancer, Institutes Review Procedure For Exceptional Cases

October 21, 2011

NCI Will Reissue Two RFPs On Smoking TWG Will Hear Artificial Tobacco Work

September 6, 1974

NCI-Approved Clinical Trials

November 26, 2004

Other Concepts Approves By DCE Board Last Week

June 20, 1986

California approves $3 billion program for stem-cell research.

November 5, 2004

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997